Cover Image

Debiasing hazard-based, time-varying vaccine effects using vaccine-irrelevant infections: An observational extension of a pivotal Phase 3 COVID-19 vaccine efficacy trial

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Ashby, Ethan, Follmann, Dean, Janes, Holly, Gilbert, Peter B., Ye, Ting, Baden, Lindsey R., Sahly, Hana M. El, Zhang, Bo
Format:	Preprint
Published:	2025
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve
by: Zhao, Ziwei, et al.
Published: (2024)

Natural direct effects of vaccines and post-vaccination behaviour
by: Gonçalves, Bronner P., et al.
Published: (2026)

Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
by: Zhao, Pan, et al.
Published: (2026)

The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials
by: Chen, Zhe, et al.
Published: (2023)

Target trial emulation without matching: a more efficient approach for evaluating vaccine effectiveness using observational data
by: Wu, Emily, et al.
Published: (2025)

Equity considerations in COVID-19 vaccine allocation modelling: a literature review
by: Rumpler, Eva, et al.
Published: (2024)

The impact of Women's empowerment on childhood vaccination coverage in Nigeria: a spatio-temporal analysis
by: Gayawan, Ezra, et al.
Published: (2025)

Optimising pandemic response through vaccination strategies using neural networks
by: Zhai, Chang, et al.
Published: (2025)

It is time to thoroughly evaluate the risks of mRNA drug and vaccine toxicity
by: Ruoyang Zhao, et al.
Published: (2024)

Contrasting pre-vaccine COVID-19 waves in Italy through Functional Data Analysis
by: Boschi, Tobia, et al.
Published: (2023)

Determining vaccine responders in the presence of baseline immunity using single-cell assays and paired control samples
by: Chen, Zhe, et al.
Published: (2025)

A Bayesian mixed-effects model to evaluate the determinants of COVID-19 vaccine uptake in the US
by: Dey, Asim K.
Published: (2025)

Monitoring overall survival in pivotal trials in indolent cancers
by: Fleming, Thomas R, et al.
Published: (2023)

A mixture distribution approach for assessing genetic impact from twin study
by: Hu, Zonghui, et al.
Published: (2025)

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams
by: Morsomme, Raphael, et al.
Published: (2025)

Adoption and implication of the Biased-Annotator Competence Estimation (BACE) model into COVID-19 vaccine Twitter data: Human annotation for latent message features
by: Sun, Luhang, et al.
Published: (2023)

Status of HIV vaccine development: progress and promise
by: Barton F. Haynes, et al.
Published: (2025)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
by: Szurewsky, Chloé, et al.
Published: (2025)

Bayesian calendar-time survival analysis with epidemic curve priors and variant-specific infection hazards
by: Dahl, Angela M, et al.
Published: (2026)

Vaccine Efficacy Estimands Implied by Common Estimators Used in Individual Randomized Field Trials
by: Fay, Michael P., et al.
Published: (2026)

Assessment of mycoplasma vaccine efficacy in reducing infection with Newcastle disease virus
by: Hala Mahmoud
Published: (2023)

Methods for non-proportional hazards in clinical trials: A systematic review
by: Bardo, Maximilian, et al.
Published: (2023)

Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
by: Cao, Zhi, et al.
Published: (2025)

A group testing based exploration of age-varying factors in chlamydia infections among Iowa residents
by: Li, Yizeng, et al.
Published: (2024)

Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials
by: Andrea Callegaro, et al.
Published: (2024)

Smooth hazards with multiple time scales
by: Carollo, Angela, et al.
Published: (2023)

HPAI vaccination trial begins in England
Published: (2026)

Vaccine efficacy for binary post-infection outcomes under misclassification without monotonicity
by: Trangucci, Rob, et al.
Published: (2022)

Statistics of extremes for natural hazards: landslides and earthquakes
by: Yadav, Rishikesh, et al.
Published: (2024)

Sequential Covariance Fitting for InSAR Phase Linking
by: Hajjar, Dana El, et al.
Published: (2025)

A novel Phase I clinical trial design with unequal cohort sizes
by: Zhu, Xiaojun
Published: (2024)

Semiparametric logistic regression for inference on relative vaccine efficacy in case-only studies with informative missingness
by: van der Laan, Lars, et al.
Published: (2023)

Efficacy and immunogenicity of AS04‐HPV‐16/18 vaccine in females with existing cervical HR‐HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide
by: Tian‐Meng Wen, et al.
Published: (2024)

Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ashby, Ethan, et al.
Published: (2024)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)

Nonequilibrium antigen recognition during infections and vaccinations
by: Morán-Tovar, Roberto, et al.
Published: (2023)

The effect of the vaccine on the severity of infection on children with mumps
by: Venus Hassan Abdul Amir
Published: (2021)

Nonparametric bounds for vaccine effects in randomized trials
by: Axelrod, Rachel, et al.
Published: (2025)

Time-varying confounding in epidemic intervention evaluations
by: Zhang, Yichi, et al.
Published: (2025)

Carbon costs of different pathways for reducing fire hazard in the Sierra Nevada
by: Yihong Zhu, et al.
Published: (2025)